NO883883L - Rekombinante eukariote celler som fremstiller interleukin-2, fremgangsmaater og vektorer ved deres fremstilling og fremgangsmaate ved fremstilling av interleukin-2. - Google Patents

Rekombinante eukariote celler som fremstiller interleukin-2, fremgangsmaater og vektorer ved deres fremstilling og fremgangsmaate ved fremstilling av interleukin-2.

Info

Publication number
NO883883L
NO883883L NO88883883A NO883883A NO883883L NO 883883 L NO883883 L NO 883883L NO 88883883 A NO88883883 A NO 88883883A NO 883883 A NO883883 A NO 883883A NO 883883 L NO883883 L NO 883883L
Authority
NO
Norway
Prior art keywords
procedures
interleukin
eukariote
recombinant
vectors
Prior art date
Application number
NO88883883A
Other languages
English (en)
Norwegian (no)
Other versions
NO883883D0 (no
Inventor
Johannes Lupker
Brigitte Miloux
Willem Roskam
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO883883D0 publication Critical patent/NO883883D0/no
Publication of NO883883L publication Critical patent/NO883883L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO88883883A 1987-09-01 1988-08-31 Rekombinante eukariote celler som fremstiller interleukin-2, fremgangsmaater og vektorer ved deres fremstilling og fremgangsmaate ved fremstilling av interleukin-2. NO883883L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712166A FR2619719B1 (fr) 1987-09-01 1987-09-01 Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices

Publications (2)

Publication Number Publication Date
NO883883D0 NO883883D0 (no) 1988-08-31
NO883883L true NO883883L (no) 1989-03-02

Family

ID=9354552

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883883A NO883883L (no) 1987-09-01 1988-08-31 Rekombinante eukariote celler som fremstiller interleukin-2, fremgangsmaater og vektorer ved deres fremstilling og fremgangsmaate ved fremstilling av interleukin-2.

Country Status (12)

Country Link
EP (1) EP0307285A1 (ko)
JP (1) JPH01165373A (ko)
KR (1) KR890005264A (ko)
AU (1) AU606453B2 (ko)
DK (1) DK467188A (ko)
FI (1) FI884036A (ko)
FR (1) FR2619719B1 (ko)
IL (1) IL87622A0 (ko)
NO (1) NO883883L (ko)
NZ (1) NZ225983A (ko)
PT (1) PT88372B (ko)
ZA (1) ZA886517B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells
US5417970A (en) * 1988-10-21 1995-05-23 Sanofi Drugs containing a glycosylated interleukin-2
FR2639232A1 (fr) * 1988-10-21 1990-05-25 Sanofi Sa Medicaments contenant une interleukine-2 glycosylee
WO1990015142A1 (en) * 1989-06-09 1990-12-13 Gropep Pty. Ltd. Growth hormone fusion proteins
US5679771A (en) * 1990-02-13 1997-10-21 Gropep Pty. Ltd. Method for treating intestinal diseases
IL126121A0 (en) * 1996-05-01 1999-05-09 Genitope Corp Vaccines for treatment of lymphoma and leukemia
US5776746A (en) 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
AU4424497A (en) * 1996-09-13 1998-04-02 Transkaryotic Therapies, Inc. Therapy for alpha-galactosidase a deficiency
US6083725A (en) * 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
ATE243045T1 (de) 1997-11-20 2003-07-15 Vical Inc Behandlung von krebs durch verwendung von zytokin-exprimierender polynukleotiden und zusammensetzungen dafür
KR20020043448A (ko) * 2000-12-04 2002-06-10 리송알렉스인근 인터루킨-2 재조합 단백질 및 그의 제조방법
IL140110A0 (en) * 2000-12-05 2002-02-10 Applied Research Systems Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
US20040071686A1 (en) 2002-04-25 2004-04-15 Treco Douglas A. Treatment of alpha-galactosidase A deficiency
MA40094B1 (fr) 2014-08-06 2022-05-31 Univ Miami Protéines de fusion de l'interleukine-2/récepteur alpha de l'interleukine-2 et procédés d'utilisation
EP3990479A4 (en) * 2019-06-26 2023-08-02 The Johns Hopkins University METHODS AND MATERIALS FOR TARGETED EXPANSION OF IMMUNE EFFECTOR CELLS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0172619A1 (en) * 1984-06-20 1986-02-26 Takeda Chemical Industries, Ltd. Novel transformant and use thereof
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells

Also Published As

Publication number Publication date
DK467188D0 (da) 1988-08-19
FR2619719A1 (fr) 1989-03-03
JPH01165373A (ja) 1989-06-29
AU606453B2 (en) 1991-02-07
KR890005264A (ko) 1989-05-13
FR2619719B1 (fr) 1991-05-10
IL87622A0 (en) 1989-01-31
ZA886517B (en) 1989-05-30
NO883883D0 (no) 1988-08-31
AU2179688A (en) 1989-03-02
FI884036A0 (fi) 1988-09-01
FI884036A (fi) 1989-03-02
EP0307285A1 (fr) 1989-03-15
NZ225983A (en) 1990-09-26
DK467188A (da) 1989-03-02
PT88372A (pt) 1989-07-31
PT88372B (pt) 1993-04-30

Similar Documents

Publication Publication Date Title
NO883883L (no) Rekombinante eukariote celler som fremstiller interleukin-2, fremgangsmaater og vektorer ved deres fremstilling og fremgangsmaate ved fremstilling av interleukin-2.
NO872228D0 (no) Farmakologisk aktive diaryl-3-substituert-pyrazoler og fremgangsmaate for deres fremstilling.
NO902661D0 (no) Ribozymer, deres fremstilling og anvendelse.
NO871845L (no) 5-aralkyl-4-alkoksy-2(5h)-furanon, mellomprodukter og en fremgangsmaate for deres fremstilling.
NO872968L (no) Bimodale stjerneblokk-copolymerer og fremgangsmŸte ved deres fremstilling.
IT8422580A0 (it) Composizioni che le contengono e proteine di membrana cellulare, procedimento per prepararle.
NO900469D0 (no) Piperidinforbindelser, deres fremstilling og anvendelse.
DK638389A (da) Transformerende vaekstfaktor-beta2 og forstadier derfor, fremgangsmaade til deres fremstilling, nucleotidsekvens som koder derfor samt eukaryotiske celler og cellelinier indeholdende denne
NO871025L (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO870512L (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
AU4307589A (en) Self-inactivating, replication defective, retroviral vectors and helper cells for producing the same
NO882766L (no) Katalysatorer og fremgangsmaate for deres fremstilling.
DK85084A (da) Immunglobulin-producerende hybridcellelinier, deres anvendelse og fremgangsmaade til deres fremstilling
FI884361A0 (fi) Foertjockad, vattenhaltig tvaettblandning innehaollande litet eller inget fosfat.
NO892869L (no) Heteropolysakkarider, fremgangsmaate for deres fremstilling og anvendelse.
NO890894D0 (no) 4-substituerte pyrazolo(3,4-alfa)pyrimidinderivater og fremgangsmaate for deres fremstilling.
NO902291D0 (no) Elektrokjemiske celler.
DE68905705D1 (de) Sphaerische phosphoraggregate, ihre herstellung und verwendung in roentgenstrahlschirmen.
NO871643D0 (no) Benzimidazolsulfonamider, imidazopyridinsulfonamider og fremgangsmaate til deres fremstilling.
DK350985A (da) Octapeptider, deres fremstilling og anvendelse som angiotensin-ii-antigonister samt mellemprodukter ved fremstillingen
DK522985D0 (da) Triazolylmethylcarbinol-arylacetaler, deres fremstilling og anvendelse
NO903342L (no) Gallesyresulfatsulfatase, fremgangsmaate for fremstilling derav og fremgangsmaate for aa maale gallesyre.
FI882887A0 (fi) Foer klaeder avsedd tvaett- och/eller torkmaskin, vars trumma staengs med regel.
NO872885L (no) 1,3,5-tritianderivater og fremgangsmŸte for deres fremstilling.